Search results
Results from the WOW.Com Content Network
The CDC/NIH publication, "Biosafety in Microbiological and Biomedical Laboratories." [17] The Occupational Safety and Health Administration (OSHA) regulations in 29 CFR parts 1910.1200 and 1910.1450. [17] The "NIH Guidelines for Research Involving Recombinant DNA Molecules" (NIH Guidelines). [17]
The NIH Office of Science Policy works on a wide range of issues including biosafety, [2] biosecurity, [3] genetic testing, genomic data sharing, [4] human subjects protections, [5] the organization and management of the NIH, and the outputs and value of NIH-funded research. This is accomplished through a wide range of analyses and reports ...
One of the programs within the Roadmap, Re-engineering the Clinical Research Enterprise, called for developing rigorous and systematic infrastructure for clinical research and for translating scientific discoveries into practical applications or tools that can be used by healthcare providers. [4] PROMIS is one initiative within this program.
The National Center for Biotechnology Information (NCBI) [1] [2] is part of the (NLM), a branch of the National Institutes of Health (NIH). It is approved and funded by the government of the United States. The NCBI is located in Bethesda, Maryland, and was founded in 1988 through legislation sponsored by US Congressman Claude Pepper.
In FY 2016, the total number of grant applications received by the NIH was 54,220, with approximately 19% being awarded funding. [66] Institutes have varying funding rates. The National Cancer Institute awarded funding to 12% of applicants, while the National Institute for General Medical Science awarded funding to 30% of applicants. [66]
Clinical research is a branch of medical research that involves people and aims to determine the effectiveness and safety of medications, devices, diagnostic products, and treatment regimens intended for improving human health.
The NIH was therefore free to give federal funding to experiments involving the cells themselves. President Clinton strongly endorses the new guidelines, noting that human embryonic stem cell research promised "potentially staggering benefits." And with the guidelines in place, the NIH begins accepting grant proposals from scientists. [36]
The name "Health Level-7" is a reference to the seventh layer of the ISO OSI Reference model also known as the application layer. The name indicates that HL7 focuses on application layer protocols for the health care domain, independent of lower layers. HL7 effectively considers all lower layers merely as tools. [7]